SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021917
Filing Date
2022-11-03
Accepted
2022-11-03 16:28:31
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kpti-20220930.htm   iXBRL 10-Q 3633369
2 EX-31.1 kpti-ex31_1.htm EX-31.1 14499
3 EX-31.2 kpti-ex31_2.htm EX-31.2 14535
4 EX-32.1 kpti-ex32_1.htm EX-32.1 8957
5 EX-32.2 kpti-ex32_2.htm EX-32.2 9272
  Complete submission text file 0000950170-22-021917.txt   9862941

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kpti-20220930_def.xml EX-101.DEF 197685
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kpti-20220930_cal.xml EX-101.CAL 49595
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kpti-20220930_pre.xml EX-101.PRE 304681
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kpti-20220930.xsd EX-101.SCH 48596
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kpti-20220930_lab.xml EX-101.LAB 409838
55 EXTRACTED XBRL INSTANCE DOCUMENT kpti-20220930_htm.xml XML 1759834
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 221358477
SIC: 2834 Pharmaceutical Preparations